Broker Regulation

While the overwhelming majority of Americans are not on Medicaid, it is important to recognize that sharp funding cuts to Medicaid would not only affect program recipients, but also the financial wellbeing of countless hospitals and community health centers.

Medicare Part D spending for 10 selected diabetes drugs surged from $7.7 billion in 2019 to $35.8 billion in 2023, an audit by the U.S. Department of Health and Human Services Office of Inspector General found.

One of every four dollars in federal spending in fiscal year 2024 was used to pay for health programs and services.

After turning over more than 1,300 documents to the Federal Trade Commission, the fast food giant is turning its attention to subpoenas from pharmacy benefit managers the agency accuses of artificially inflating insulin prices.

The DOGE team's request is part of a plan to cut federal spending by $1 trillion, with Medicaid cuts likely.

In this interview, we discuss fiduciary responsibilities, PBM contracts, and litigation risks with two industry experts.